Skip to main content

Table 1 Characteristics and clinical presentation for six dogs exposed to anticoagulant rodenticides (ARs)

From: Determination of anticoagulant rodenticides in faeces of exposed dogs and in a healthy dog population

Case numberAge
Clinical signsCoagulation statusDetected ARsTreatmentDuration of detectable AR concentrations after ingestion
10.57L, PMM, TP, DP, TProlongedBrodifacoumVitamin K1, oxygen, fluids7At least 969a
226L, PMM, TP, DP, T, I, LTProlongedBrodifacoumBlood transfusion, Vitamin K1, oxygen, fluids53bAt least 894b
3816NoneNormalBrodifacoumEmeticum, activated charcoal9At least 700
40.611NoneNormalBromadioloneEmeticum, activated charcoaln.d.151
50.822NoneNormalBromadioloneEmeticum, activated charcoal, fluidsn.d.3
69.526NoneProlonged (day 3)DifenacoumEmeticum, Vitamin K19At least 653
  1. n.d. Not detected, L lethargy, PMM pale mucous membranes, TP tachypnea, DP dyspnea, T tachycardia, I inappetence, LT low temperature
  2. aProbable new exposure detected day 1032
  3. bAfter first visit, day of ingestion unknown